The cost for ALMIS - minimal invasive hip arthroplasty in China typically ranges from $17,000 to $26,000. Total pricing depends on the hospital tier and the specific hip prosthesis selected. In the US, this procedure costs $47,500 on average. Most Chinese medical programs include surgeon fees, anesthesia, the implant, and a standard hospital stay.
Bookimed Expert Insight. Chinese tertiary hospitals offer high-volume expertise with over 30,000 patients annually at centers like Guangzhou Cihua Hospital. Accessing international departments allows treatment from doctoral supervisors like Professor Chen Biao in Shanghai. These departments provide translation and 1:one physical therapy. Choosing a facility with both MRI and densitometry scanners ensures precise preoperative planning.
| China | Turkey | Austria | |
| ALMIS - minimal invasive hip arthroplasty | ≈ $17,000 | from $8,000 | ≈ $14,500 |
No hidden fees – just official clinic prices. Pay at the clinic for ALMIS - minimal invasive hip arthroplasty upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in ALMIS - minimal invasive hip arthroplasty and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your ALMIS - minimal invasive hip arthroplasty journey.
Day 1
Day 2
Day 3
Day 4
Day 5
Week 1
Week 2-4
Week 5-8
Week 8-12
Please note: each individual"s recovery may vary based on their health status and age.
Professor Cheng Biao is Chief Physician, Professor, and Doctoral Supervisor of Orthopedics at Shanghai Tongji Hospital. He specializes in complex joint disease and sports trauma. His focus areas are arthroplasty and arthroscopy.
Scope includes knee and hip arthroplasty, meniscectomy, and rotator cuff, ACL, and Bankart repair. He also treats DDH, patellar and shoulder instability, axial spondyloarthritis, Kashin–Beck disease, and major‑joint osteoarthritis.
He is Deputy Head of the Arthroscopy Group, Shanghai Medical Doctor Association, and a founding member of the Chinese Shoulder & Elbow Collaborative. His awards include the Shanghai Medical Science & Technology Award (Third Prize) and the Shanghai Science & Technology Progress Award. He also serves as an international medical expert at the Shanghai World International Medical Center.